TGA Approval

OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe (citrate-free formulation) (461088)

ARTG ID

461088

ARTG Name

OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe (citrate-free formulation)

Sponsor

Eli Lilly Australia Pty Ltd

ARTG Date

July 4, 2025

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ELI LILLY AUSTRALIA PTY LTD

Ingredient Name

mirikizumab

Empowering clinical research with data-driven insights and AI-powered tools.

OMVOH mirikizumab 100 mg/mL solution for injection pre-filled syringe (citrate-free formulation) (461088) - TGA 批准文号 | MedPath